Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adalimumab level in breast milk of a nursing mother.
Ben-Horin S, Yavzori M, Katz L, Picard O, Fudim E, Chowers Y, Lang A. Ben-Horin S, et al. Among authors: yavzori m. Clin Gastroenterol Hepatol. 2010 May;8(5):475-6. doi: 10.1016/j.cgh.2009.11.023. Epub 2010 Jan 6. Clin Gastroenterol Hepatol. 2010. PMID: 20005982 No abstract available.
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a post hoc analysis.
Yablecovitch D, Kopylov U, Lahat A, Amitai MM, Klang E, Ben-Ami Shor D, Neuman S, Levhar N, Fudim E, Avidan B, Laish I, Selinger L, Zingboim-Orbach N, Picard O, Yavzori M, Eliakim R, Ben-Horin S. Yablecovitch D, et al. Among authors: yavzori m. Therap Adv Gastroenterol. 2019 Oct 9;12:1756284819881590. doi: 10.1177/1756284819881590. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31636712 Free PMC article.
Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease.
Ben-Horin S, Waterman M, Kopylov U, Yavzori M, Picard O, Fudim E, Awadie H, Weiss B, Chowers Y. Ben-Horin S, et al. Among authors: yavzori m. Clin Gastroenterol Hepatol. 2013 Apr;11(4):444-7. doi: 10.1016/j.cgh.2012.10.020. Epub 2012 Oct 24. Clin Gastroenterol Hepatol. 2013. PMID: 23103905
Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases.
Ungar B, Levy I, Yavne Y, Yavzori M, Picard O, Fudim E, Loebstein R, Chowers Y, Eliakim R, Kopylov U, Ben-Horin S. Ungar B, et al. Among authors: yavzori m. Clin Gastroenterol Hepatol. 2016 Apr;14(4):550-557.e2. doi: 10.1016/j.cgh.2015.10.025. Epub 2015 Oct 29. Clin Gastroenterol Hepatol. 2016. PMID: 26538204
Detection of Ustekinumab in Breast Milk of Nursing Mothers With Crohn Disease.
Bar-Gil Shitrit A, Ben-Horin S, Mishael T, Hoyda A, Yavzori M, Picard O, Grisaru-Granovsky S, Helman S. Bar-Gil Shitrit A, et al. Among authors: yavzori m. Inflamm Bowel Dis. 2021 Apr 15;27(5):742-745. doi: 10.1093/ibd/izaa325. Inflamm Bowel Dis. 2021. PMID: 33386732 No abstract available.
Association of Vedolizumab Level, Anti-Drug Antibodies, and α4β7 Occupancy With Response in Patients With Inflammatory Bowel Diseases.
Ungar B, Kopylov U, Yavzori M, Fudim E, Picard O, Lahat A, Coscas D, Waterman M, Haj-Natour O, Orbach-Zingboim N, Mao R, Chen M, Chowers Y, Eliakim R, Ben-Horin S. Ungar B, et al. Among authors: yavzori m. Clin Gastroenterol Hepatol. 2018 May;16(5):697-705.e7. doi: 10.1016/j.cgh.2017.11.050. Epub 2017 Dec 7. Clin Gastroenterol Hepatol. 2018. PMID: 29223444
Postexposure treatment with doxycycline for the prevention of tick-borne relapsing fever.
Hasin T, Davidovitch N, Cohen R, Dagan T, Romem A, Orr N, Klement E, Lubezky N, Kayouf R, Sela T, Keller N, Derazne E, Halperin T, Yavzori M, Grotto I, Cohen D. Hasin T, et al. Among authors: yavzori m. N Engl J Med. 2006 Jul 13;355(2):148-55. doi: 10.1056/NEJMoa053884. N Engl J Med. 2006. PMID: 16837678 Free article. Clinical Trial.
61 results